Searched for
GLOBAL BIOPHARMA INDUSTRY
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsHere’s one thing to watch for in the next few weeks: How does the street treat disappointments in the mid-cap segment? If the reaction is l...20 Aug, 2026, 05.28 AM IST- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is volatility? There is, of course, a mathematical definition. Then there is the human definition, which is how investors feel it. In ...13 Aug, 2026, 12.04 AM IST
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...10 Aug, 2026, 03.13 PM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...06 Aug, 2026, 01.04 PM IST
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...22 May, 2026, 04.40 PM IST
- Biocon's Shaw says Budget boosts India’s health and innovation agendaThe Union Budget is making a significant investment in India's health and innovation. Biopharma has been identified as a key strategic sect...02 Feb, 2026, 02.43 PM IST
- Budget 2026 bets on biopharma, SME capital to drive resilient growth: Industry leadersThe Union Budget 2026-27 focuses on fortifying the Indian economy against global volatility through strategic investments in technology, he...02 Feb, 2026, 12.56 PM IST
- Biocon Biologics sees Biopharma SHAKTI as major boost for India’s biosimilar ambitionsIndia's biopharmaceutical sector receives a significant boost with the Union Budget's ₹10,000 crore Biopharma SHAKTI programme. This initia...01 Feb, 2026, 03.21 PM IST
- Budget 2026: Sitharaman launches 'Biopharma Shakti' with a Rs 10,000-crore bet to heal India, power manufacturingUnion Budget 2026: With the announcement of the 'Biopharma Shakti' initiative, India is gearing up to take the world stage in biopharmaceut...01 Feb, 2026, 01.39 PM IST
- Budget 2026: Sitharaman’s six-point plan to propel India’s next growth phaseUnion Budget 2026: Finance Minister Nirmala Sitharaman has presented a six-point plan to boost India's economy. The strategy prioritizes ma...01 Feb, 2026, 11.40 AM IST
- India emerging as favourable destination to conduct global clinical trials: ReportThe joint report by the USA India Chamber of Commerce & PwC India titled, “Clinical Trial opportunities in India” which will be released at...03 May, 2023, 11.03 AM IST
- PharmNXT Biotech unveils first integrated manufacturing unit for single use bioprocessing systemsThe new facility was launched at the PharmNXT Biotech LLP, the company’s facility in Chakan, Pune.11 Oct, 2022, 12.54 PM IST
- Top government officials, leaders from industry, academicians to take part in India-US Biopharma and Healthcare SummitNITI Aayog CEO Amitabh Kant, Pfizer CEO Dr Alberta Bourla, National Institutes of Health (NIH) Director Dr Francis Collins and Food and Dru...19 Jun, 2021, 10.15 AM IST
- Pharma sector needs global collaboration: Industry leaders, government officialsAhead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...31 Aug, 2020, 08.49 AM IST
- Telangana plans country’s first biopharma hubTelangana government proposes to set up India’s first Biopharma-Hub to provide support to the biopharma research and development activities.01 Aug, 2018, 10.50 AM IST
- Policy, infrastructure main hurdles in Indian pharma R&D: ReportThe McKinsey report commissioned by the US-India Chamber of Commerce would be released at the US-India BioPharma and Healthcare Summit 2013...20 Jun, 2013, 01.40 PM IST
- Intas Biopharma in talks with Japanese co for outlicensingIntas Biopharmaceutical Ltd, a group company of the Rs 1,600-crore Intas Pharmaceuticals Ltd, would soon enter into an out-licensing and su...27 Sep, 2010, 12.24 PM IST
Load More
